Neurology and Neurosurgery: Current Research

Volume 1, Issue 1 (2020)

Mini Review - Open Access
A Mini Review on Neurodegenerative Huntington Disease

Aleksandra Pikula*

Department of Neurology, Boston University School of Medicine, USA

*Corresponding Author:
Dr. Aleksandra Pikula
Department of Neurology, Boston University School of Medicine, USA.

Received date: November 04, 2020; Accepted date: November 23, 2020; Published date: November 30, 2020

Citation: Pikula A (2020) A Mini Review on Neurodegenerative Huntington Disease. Neurol Neurosurg Curr Res. 2020;1(1): 1-5.

Copyright: © 2020 Pikula A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


The heterogeneous group of disorders characterized by the gradual degradation of the structure and function of the central nervous system or the peripheral nervous system are neurodegenerative diseases (NDs). Millions of people worldwide are affected by NDs, and the most common forms are Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). Huntington’s disease is a rare, hereditary disease that causes nerve cells in the brain to slowly break down (degenerate). It has a broad effect on the mental ability of an individual and typically results in movement, perception (cognitive) and psychiatric disorders. It is caused by the HTT gene mutation and is inherited in an autosomal dominant way. Treatment is based on the symptoms that are present in each person and can involve different medications.


Neurodegenerative diseases; Huntington’s disease; Alzheimer’s disease; Parkinson’s disease